Season 1, Episode 3
Jan 16, 2020•22 min
Episode description
In this episode we highlight the development of intensified T-cell acute lymphoblastic leukemia-focused protocols, the use of a thrombopoietin agonist for thrombocytopenia following allogeneic hematopoieticstem cell transplantation, and a crucial step forward in the development of miRNA therapies targeting myeloid diseases.
For the best experience, listen in Metacast app for iOS or Android
